DOI: 10.1053/j.seminhematol.2005.12.009. Purine Analogue-Based Chemotherapy Regimens for Second-Line Therapy in Patients With Chronic Lymphocytic Leukemia

Purine Analogue-Based Chemotherapy Regimens for Second-Line Therapy in Patients With Chronic Lymphocytic Leukemia

10.1053/j.seminhematol.2005.12.009

Crossref journal-article

Elsevier BV

Seminars in Hematology (78)

Bibliography

Lamanna, N., & Weiss, M. A. (2006). Purine Analogue-Based Chemotherapy Regimens for Second-Line Therapy in Patients With Chronic Lymphocytic Leukemia. Seminars in Hematology, 43, S44âS49.

Authors 2

Nicole Lamanna (first)
Mark A. Weiss (additional)

References 45 Referenced 3

10.1002/(SICI)1097-0142(19991215)86:12<2684::AID-CNCR13>3.0.CO;2-V / Cancer / The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia by Diehl (1999)
10.1182/blood.V85.2.307.307 / Blood / Advances in the biology and treatment of B-cell chronic lymphocytic leukemia by O’Brien (1995)
{'key': '10.1053/j.seminhematol.2005.12.009_bib3', 'first-page': '42', 'article-title': 'Chronic lymphocytic leukemia', 'volume': '25', 'author': 'Zwiebel', 'year': '1998', 'journal-title': 'Semin Oncol'} / Semin Oncol / Chronic lymphocytic leukemia by Zwiebel (1998)
10.1056/NEJM200012283432602 / N Engl J Med / Genomic aberrations and survival in chronic lymphocytic leukemia by Dohner (2000)
10.1182/blood.V46.2.219.219 / Blood / Clinical staging of chronic lymphocytic leukemia by Rai (1975)
10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V / Cancer / A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis by Binet (1981)
10.1056/NEJM199805213382104 / N Engl J Med / Chlorambucil in indolent chronic lymphocytic leukemia by Dighiero (1998)
10.1182/blood.V75.7.1414.1414 / Blood / Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A) (1990)
10.1182/blood.V87.12.4990.bloodjournal87124990 / Blood / National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia by Cheson (1996)
10.1182/blood.V74.1.19.bloodjournal74119 / Blood / Fludarabine by Keating (1989)
10.1056/NEJM200012143432402 / N Engl J Med / Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia by Rai (2000)
10.1046/j.0007-1048.2002.03362.x / Br J Haematol / High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin’s lymphoma by Summerfield (2002)
10.1182/blood.V98.8.2319 / Blood / Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients by Leporrier (2001)
10.1016/S0140-6736(96)91681-5 / Lancet / Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia by Johnson (1996)
{'key': '10.1053/j.seminhematol.2005.12.009_bib15', 'first-page': '2723', 'article-title': 'Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia', 'volume': '96', 'author': 'Robak', 'year': '2000', 'journal-title': 'Blood'} / Blood / Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia by Robak (2000)
10.1080/10428190290012029 / Leuk Lymphoma / The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia—Lessons learned from prospective randomized trials by Robak (2002)
10.2165/00003495-199346040-00006 / Drugs / Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders by Brogden (1993)
10.1016/S0140-6736(72)92345-8 / Lancet / Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity by Giblett (1972)
10.1002/1099-1069(200012)18:4<141::AID-HON666>3.0.CO;2-# / Hematol Oncol / Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies by Johnson (2000)
{'key': '10.1053/j.seminhematol.2005.12.009_bib20', 'first-page': '457', 'article-title': 'Fludarabine monophosphate', 'volume': '30', 'author': 'Grever', 'year': '1988', 'journal-title': 'Nouv Rev Fr Hematol'} / Nouv Rev Fr Hematol / Fludarabine monophosphate by Grever (1988)
10.1182/blood.V82.6.1695.1695 / Blood / Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment by O’Brien (1993)
10.1182/blood.V92.4.1165 / Blood / Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy by Keating (1998)
10.1200/JCO.1991.9.1.44 / J Clin Oncol / Fludarabine by Keating (1991)
{'key': '10.1053/j.seminhematol.2005.12.009_bib24', 'first-page': '361', 'article-title': 'A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia', 'volume': '7', 'author': 'Elias', 'year': '1993', 'journal-title': 'Leukemia'} / Leukemia / A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia by Elias (1993)
{'key': '10.1053/j.seminhematol.2005.12.009_bib25', 'first-page': '1290', 'article-title': 'Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia', 'volume': '8', 'author': 'Weiss', 'year': '1994', 'journal-title': 'Leukemia'} / Leukemia / Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia by Weiss (1994)
10.1200/JCO.2001.19.5.1414 / J Clin Oncol / Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia by O’Brien (2001)
10.1200/JCO.2005.12.516 / J Clin Oncol / Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia by Wierda (2005)
10.1182/blood.V96.1.71 / Blood / Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies by Flinn (2000)
10.1038/sj.leu.2401892 / Leukemia / Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy by Weiss (2000)
10.1007/s11912-005-0059-0 / Curr Oncol Rep / Advances in the treatment of chronic lymphocytic leukemia by Lamanna (2005)
10.1038/sj.thj.6200191 / Hematol J / Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia by Robak (2002)
10.1182/blood.V86.5.1710.bloodjournal8651710 / Blood / 2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin’s lymphoma by Saven (1995)
10.1002/cncr.11000 / Cancer / Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia by Montillo (2003)
10.1182/blood.V57.3.406.406 / Blood / The biochemical and clinical consequences of 2′-deoxycoformycin in refractory lymphoproliferative malignancy by Grever (1981)
{'key': '10.1053/j.seminhematol.2005.12.009_bib35', 'first-page': '334', 'article-title': 'Repeated pentostatin (2′deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia', 'volume': '148', 'author': 'Dillman', 'year': '1988', 'journal-title': 'West J Med'} / West J Med / Repeated pentostatin (2′deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia by Dillman (1988)
10.1200/JCO.1989.7.4.433 / J Clin Oncol / Pentostatin in chronic lymphocytic leukemia by Dillman (1989)
10.1093/jnci/82.17.1416 / J Natl Cancer Inst / Pentostatin in refractory chronic lymphocytic leukemia by Ho (1990)
10.1023/A:1006100900082 / Invest New Drugs / Phase I/II evaluation of pentostatin (2′-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia by Johnson (1998)
{'issue': 'suppl 1', 'key': '10.1053/j.seminhematol.2005.12.009_bib39', 'first-page': 'S140', 'article-title': 'Combination therapy with nucleoside analogues and alkylating agents', 'volume': '8', 'author': 'Johnston', 'year': '1994', 'journal-title': 'Leukemia'} / Leukemia / Combination therapy with nucleoside analogues and alkylating agents by Johnston (1994)
10.1056/NEJM198704023161401 / N Engl J Med / Remissions in hairy-cell leukemia with pentostatin (2′-deoxycoformycin) by Spiers (1987)
10.1182/blood.V61.2.279.279 / Blood / An investigation of 2′-deoxycoformycin in the treatment of cutaneous T-cell lymphoma by Grever (1983)
10.1080/1042819031000151897 / Leuk Lymphoma / Pentostatin, chlorambucil and prednisone therapy for B-chronic lymphocytic leukemia by Oken (2004)
{'key': '10.1053/j.seminhematol.2005.12.009_bib43', 'first-page': '44', 'article-title': 'Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia', 'volume': '27', 'author': 'Waselenko', 'year': '2000', 'journal-title': 'Semin Oncol'} / Semin Oncol / Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia by Waselenko (2000)
10.1200/JCO.2003.08.100 / J Clin Oncol / Pentostatin and cyclophosphamide by Weiss (2003)
10.1002/hon.742 / Hematol Oncol / Advances in the diagnosis and treatment of chronic lymphocytic leukemia by Abbott (2005)

Dates

Type	When
Created	19 years, 5 months ago (March 19, 2006, 9:09 p.m.)
Deposited	5 years, 4 months ago (April 13, 2020, 3:52 a.m.)
Indexed	1 year, 1 month ago (July 9, 2024, 3:42 p.m.)
Issued	19 years, 5 months ago (April 1, 2006)
Published	19 years, 5 months ago (April 1, 2006)
Published Print	19 years, 5 months ago (April 1, 2006)

Funders 0

None

BibTeX

@article{Lamanna_2006, title={Purine Analogue-Based Chemotherapy Regimens for Second-Line Therapy in Patients With Chronic Lymphocytic Leukemia}, volume={43}, ISSN={0037-1963}, url={http://dx.doi.org/10.1053/j.seminhematol.2005.12.009}, DOI={10.1053/j.seminhematol.2005.12.009}, journal={Seminars in Hematology}, publisher={Elsevier BV}, author={Lamanna, Nicole and Weiss, Mark A.}, year={2006}, month=apr, pages={S44–S49} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        7,
        9
      ]
    ],
    "date-time": "2024-07-09T19:42:12Z",
    "timestamp": 1720554132529
  },
  "reference-count": 45,
  "publisher": "Elsevier BV",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2006,
            4,
            1
          ]
        ],
        "date-time": "2006-04-01T00:00:00Z",
        "timestamp": 1143849600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2006,
        4
      ]
    ]
  },
  "DOI": "10.1053/j.seminhematol.2005.12.009",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2006,
        3,
        20
      ]
    ],
    "date-time": "2006-03-20T02:09:49Z",
    "timestamp": 1142820589000
  },
  "page": "S44-S49",
  "source": "Crossref",
  "is-referenced-by-count": 3,
  "special_numbering": "S2",
  "title": "Purine Analogue-Based Chemotherapy Regimens for Second-Line Therapy in Patients With Chronic Lymphocytic Leukemia",
  "prefix": "10.1053",
  "volume": "43",
  "author": [
    {
      "given": "Nicole",
      "family": "Lamanna",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Mark A.",
      "family": "Weiss",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "2684",
      "DOI": "10.1002/(SICI)1097-0142(19991215)86:12<2684::AID-CNCR13>3.0.CO;2-V",
      "article-title": "The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia",
      "volume": "86",
      "author": "Diehl",
      "year": "1999",
      "journal-title": "Cancer"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "307",
      "DOI": "10.1182/blood.V85.2.307.307",
      "article-title": "Advances in the biology and treatment of B-cell chronic lymphocytic leukemia",
      "volume": "85",
      "author": "O\u2019Brien",
      "year": "1995",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib3",
      "first-page": "42",
      "article-title": "Chronic lymphocytic leukemia",
      "volume": "25",
      "author": "Zwiebel",
      "year": "1998",
      "journal-title": "Semin Oncol"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "1910",
      "DOI": "10.1056/NEJM200012283432602",
      "article-title": "Genomic aberrations and survival in chronic lymphocytic leukemia",
      "volume": "343",
      "author": "Dohner",
      "year": "2000",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "219",
      "DOI": "10.1182/blood.V46.2.219.219",
      "article-title": "Clinical staging of chronic lymphocytic leukemia",
      "volume": "46",
      "author": "Rai",
      "year": "1975",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "198",
      "DOI": "10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V",
      "article-title": "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis",
      "volume": "48",
      "author": "Binet",
      "year": "1981",
      "journal-title": "Cancer"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "1506",
      "DOI": "10.1056/NEJM199805213382104",
      "article-title": "Chlorambucil in indolent chronic lymphocytic leukemia",
      "volume": "338",
      "author": "Dighiero",
      "year": "1998",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "1414",
      "DOI": "10.1182/blood.V75.7.1414.1414",
      "article-title": "Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A)",
      "volume": "75",
      "year": "1990",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "4990",
      "DOI": "10.1182/blood.V87.12.4990.bloodjournal87124990",
      "article-title": "National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia",
      "volume": "87",
      "author": "Cheson",
      "year": "1996",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "DOI": "10.1182/blood.V74.1.19.bloodjournal74119",
      "article-title": "Fludarabine",
      "volume": "74",
      "author": "Keating",
      "year": "1989",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "1750",
      "DOI": "10.1056/NEJM200012143432402",
      "article-title": "Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",
      "volume": "343",
      "author": "Rai",
      "year": "2000",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "781",
      "DOI": "10.1046/j.0007-1048.2002.03362.x",
      "article-title": "High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin\u2019s lymphoma",
      "volume": "116",
      "author": "Summerfield",
      "year": "2002",
      "journal-title": "Br J Haematol"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "2319",
      "DOI": "10.1182/blood.V98.8.2319",
      "article-title": "Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients",
      "volume": "98",
      "author": "Leporrier",
      "year": "2001",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "1432",
      "DOI": "10.1016/S0140-6736(96)91681-5",
      "article-title": "Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia",
      "volume": "347",
      "author": "Johnson",
      "year": "1996",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib15",
      "first-page": "2723",
      "article-title": "Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia",
      "volume": "96",
      "author": "Robak",
      "year": "2000",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "537",
      "DOI": "10.1080/10428190290012029",
      "article-title": "The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia\u2014Lessons learned from prospective randomized trials",
      "volume": "43",
      "author": "Robak",
      "year": "2002",
      "journal-title": "Leuk Lymphoma"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "652",
      "DOI": "10.2165/00003495-199346040-00006",
      "article-title": "Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders",
      "volume": "46",
      "author": "Brogden",
      "year": "1993",
      "journal-title": "Drugs"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "1067",
      "DOI": "10.1016/S0140-6736(72)92345-8",
      "article-title": "Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity",
      "volume": "2",
      "author": "Giblett",
      "year": "1972",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "141",
      "DOI": "10.1002/1099-1069(200012)18:4<141::AID-HON666>3.0.CO;2-#",
      "article-title": "Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies",
      "volume": "18",
      "author": "Johnson",
      "year": "2000",
      "journal-title": "Hematol Oncol"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib20",
      "first-page": "457",
      "article-title": "Fludarabine monophosphate",
      "volume": "30",
      "author": "Grever",
      "year": "1988",
      "journal-title": "Nouv Rev Fr Hematol"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "1695",
      "DOI": "10.1182/blood.V82.6.1695.1695",
      "article-title": "Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment",
      "volume": "82",
      "author": "O\u2019Brien",
      "year": "1993",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "1165",
      "DOI": "10.1182/blood.V92.4.1165",
      "article-title": "Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy",
      "volume": "92",
      "author": "Keating",
      "year": "1998",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "44",
      "DOI": "10.1200/JCO.1991.9.1.44",
      "article-title": "Fludarabine",
      "volume": "9",
      "author": "Keating",
      "year": "1991",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib24",
      "first-page": "361",
      "article-title": "A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia",
      "volume": "7",
      "author": "Elias",
      "year": "1993",
      "journal-title": "Leukemia"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib25",
      "first-page": "1290",
      "article-title": "Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia",
      "volume": "8",
      "author": "Weiss",
      "year": "1994",
      "journal-title": "Leukemia"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "1414",
      "DOI": "10.1200/JCO.2001.19.5.1414",
      "article-title": "Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia",
      "volume": "19",
      "author": "O\u2019Brien",
      "year": "2001",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "4070",
      "DOI": "10.1200/JCO.2005.12.516",
      "article-title": "Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia",
      "volume": "23",
      "author": "Wierda",
      "year": "2005",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "71",
      "DOI": "10.1182/blood.V96.1.71",
      "article-title": "Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies",
      "volume": "96",
      "author": "Flinn",
      "year": "2000",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "1577",
      "DOI": "10.1038/sj.leu.2401892",
      "article-title": "Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy",
      "volume": "14",
      "author": "Weiss",
      "year": "2000",
      "journal-title": "Leukemia"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "333",
      "DOI": "10.1007/s11912-005-0059-0",
      "article-title": "Advances in the treatment of chronic lymphocytic leukemia",
      "volume": "7",
      "author": "Lamanna",
      "year": "2005",
      "journal-title": "Curr Oncol Rep"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib31",
      "doi-asserted-by": "crossref",
      "first-page": "244",
      "DOI": "10.1038/sj.thj.6200191",
      "article-title": "Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia",
      "volume": "3",
      "author": "Robak",
      "year": "2002",
      "journal-title": "Hematol J"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "1710",
      "DOI": "10.1182/blood.V86.5.1710.bloodjournal8651710",
      "article-title": "2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin\u2019s lymphoma",
      "volume": "86",
      "author": "Saven",
      "year": "1995",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "114",
      "DOI": "10.1002/cncr.11000",
      "article-title": "Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia",
      "volume": "97",
      "author": "Montillo",
      "year": "2003",
      "journal-title": "Cancer"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib34",
      "doi-asserted-by": "crossref",
      "first-page": "406",
      "DOI": "10.1182/blood.V57.3.406.406",
      "article-title": "The biochemical and clinical consequences of 2\u2032-deoxycoformycin in refractory lymphoproliferative malignancy",
      "volume": "57",
      "author": "Grever",
      "year": "1981",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib35",
      "first-page": "334",
      "article-title": "Repeated pentostatin (2\u2032deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia",
      "volume": "148",
      "author": "Dillman",
      "year": "1988",
      "journal-title": "West J Med"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib36",
      "doi-asserted-by": "crossref",
      "first-page": "433",
      "DOI": "10.1200/JCO.1989.7.4.433",
      "article-title": "Pentostatin in chronic lymphocytic leukemia",
      "volume": "7",
      "author": "Dillman",
      "year": "1989",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "1416",
      "DOI": "10.1093/jnci/82.17.1416",
      "article-title": "Pentostatin in refractory chronic lymphocytic leukemia",
      "volume": "82",
      "author": "Ho",
      "year": "1990",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib38",
      "doi-asserted-by": "crossref",
      "first-page": "155",
      "DOI": "10.1023/A:1006100900082",
      "article-title": "Phase I/II evaluation of pentostatin (2\u2032-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia",
      "volume": "16",
      "author": "Johnson",
      "year": "1998",
      "journal-title": "Invest New Drugs"
    },
    {
      "issue": "suppl 1",
      "key": "10.1053/j.seminhematol.2005.12.009_bib39",
      "first-page": "S140",
      "article-title": "Combination therapy with nucleoside analogues and alkylating agents",
      "volume": "8",
      "author": "Johnston",
      "year": "1994",
      "journal-title": "Leukemia"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib40",
      "doi-asserted-by": "crossref",
      "first-page": "825",
      "DOI": "10.1056/NEJM198704023161401",
      "article-title": "Remissions in hairy-cell leukemia with pentostatin (2\u2032-deoxycoformycin)",
      "volume": "316",
      "author": "Spiers",
      "year": "1987",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib41",
      "doi-asserted-by": "crossref",
      "first-page": "279",
      "DOI": "10.1182/blood.V61.2.279.279",
      "article-title": "An investigation of 2\u2032-deoxycoformycin in the treatment of cutaneous T-cell lymphoma",
      "volume": "61",
      "author": "Grever",
      "year": "1983",
      "journal-title": "Blood"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib42",
      "doi-asserted-by": "crossref",
      "first-page": "79",
      "DOI": "10.1080/1042819031000151897",
      "article-title": "Pentostatin, chlorambucil and prednisone therapy for B-chronic lymphocytic leukemia",
      "volume": "45",
      "author": "Oken",
      "year": "2004",
      "journal-title": "Leuk Lymphoma"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib43",
      "first-page": "44",
      "article-title": "Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia",
      "volume": "27",
      "author": "Waselenko",
      "year": "2000",
      "journal-title": "Semin Oncol"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib44",
      "doi-asserted-by": "crossref",
      "first-page": "1278",
      "DOI": "10.1200/JCO.2003.08.100",
      "article-title": "Pentostatin and cyclophosphamide",
      "volume": "21",
      "author": "Weiss",
      "year": "2003",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "10.1053/j.seminhematol.2005.12.009_bib45",
      "doi-asserted-by": "crossref",
      "first-page": "34",
      "DOI": "10.1002/hon.742",
      "article-title": "Advances in the diagnosis and treatment of chronic lymphocytic leukemia",
      "volume": "23",
      "author": "Abbott",
      "year": "2005",
      "journal-title": "Hematol Oncol"
    }
  ],
  "container-title": "Seminars in Hematology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0037196305002660?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0037196305002660?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2020,
        4,
        13
      ]
    ],
    "date-time": "2020-04-13T07:52:14Z",
    "timestamp": 1586764334000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0037196305002660"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2006,
        4
      ]
    ]
  },
  "references-count": 45,
  "alternative-id": [
    "S0037196305002660"
  ],
  "URL": "http://dx.doi.org/10.1053/j.seminhematol.2005.12.009",
  "relation": {},
  "ISSN": [
    "0037-1963"
  ],
  "subject": [],
  "container-title-short": "Seminars in Hematology",
  "published": {
    "date-parts": [
      [
        2006,
        4
      ]
    ]
  }
}